The Branded Health Service Medicines (Costs) (Amendment) Regulations 2024
These Regulations amend the Branded Health Service Medicines (Costs) Regulations 2018 (S.I. 2018/345) (the “Statutory Scheme Regulations”). The amendments update the payment percentages and introduce a new approach for calculating the amount of the net sales income manufacturers and suppliers subject to the Statutory Scheme Regulations will pay to the Secretary of State based on whether the supplies of the presentations are of newer presentations or older presentations.
Sign in to trackLast fetched 03 May 2026 · legislation.gov.uk
Lifecycle
Department
Made
03 Dec 2024
—
In force
01 Jan 2025
Enabling power
The Secretary of State for Health and Social Care makes the following Regulations in exercise of the powers conferred by sections 263(1)(b) and (c), (2), (4), (5) and (5A), 264(1), 264A(2), (4), (5) and (7), 265(1), 266(1) and 272(7)(a) and (b) and (8) of the National Health Service Act 2006having had regard to the matters specified in section 266(3), (4) and (4A) of that Act. The Secretary of State has consulted in accordance with sections 263(1) and (1A), 264(1), 264C(1) and 265(9) of that Act.
DocumentsOpen on legislation.gov.uk →